In a previous study, we reported that promoter CpG island methylation was significantly lower in the basal-like subtype of breast cancer than in the other subtypes, and the methylation of promoter CpG islands was inversely related to stem cell phenotypes as revealed by CD44+/CD24− and ALDH1 expression [28]. The gene discussed is CD44; the disease is breast cancer.